Home > Healthcare > Erectile Dysfunction Device Market > Table of Contents

Erectile Dysfunction Device Market - By Device Type (Non-Surgical Devices, Surgical Devices), By Age Group (<40, 40 -60 years, >60), By Cause (Diabetes, Neurological disorders, Hypertension), By End-use (Hospitals, Clinics, ASCs) & Forecast, 2024 – 2032

  • Report ID: GMI9193
  • Published Date: Apr 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1   Market scope & definitions

1.2   Research design

1.2.1   Research approach

1.2.2   Data collection methods

1.3   Base estimates & calculations

1.3.1   Base year calculation

1.3.2   Key trends for market estimation

1.4   Forecast model

1.5   Primary research and validation

1.5.1   Primary sources

1.5.2   Data mining sources

Chapter 2   Executive Summary

2.1   Industry 360-degree synopsis

Chapter 3   Industry Insights

3.1   Industry ecosystem analysis

3.2   Industry impact forces

3.2.1   Growth drivers

3.2.1.1   Increasing prevalence of erectile dysfunction

3.2.1.2   Technological advancement in devices

3.2.1.3   Growing awareness and acceptance

3.2.1.4   Rise in R&D investment

3.2.2   Industry pitfalls & challenges

3.2.2.1   Risk of complications

3.3   Growth potential analysis

3.4   Regulatory landscape

3.5   Technological landscape

3.6   Reimburesemet scenario

3.7   Porter's analysis

3.8   PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1   Introduction

4.2   Company matrix analysis

4.3   Competitive analysis of major market players

4.4   Competitive positioning matrix

4.5   Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Device type, 2021 – 2032 ($ Mn)

5.1   Key trends

5.2   Non-surgical devices

5.2.1   Erectile dysfunction shockwave generators

5.2.2   Vacuum constriction devices

5.2.3   External penile rigidity devices

5.3   Surgical devices

5.3.1   Penile implants

5.3.1.1   Inflatable implants

5.3.1.2   Malleable implants

5.3.2   Other surgical devices

Chapter 6   Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)

6.1   Key trends

6.2   Less than 40

6.3. 40-60   years

6.4   More than 60 years

Chapter 7   Market Estimates and Forecast, By Cause, 2021 – 2032 ($ Mn)

7.1   Key trends

7.2   Diabetes

7.3   Neurological disorders

7.4   Hypertension

7.5   Other causes

Chapter 8   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)

8.1   Key trends

8.2   Hospitals

8.3   Clinics

8.4   Ambulatory surgical centers

8.5   Other end-users

Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

9.1   Key trends

9.2   North America

9.2.1    U.S.

9.2.2    Canada

9.3   Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Netherlands

9.3.7    Rest of Europe

9.4   Asia Pacific

9.4.1    China

9.4.2    Japan

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Rest of Asia Pacific

9.5   Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Rest of Latin America

9.6   Middle East and Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    UAE

9.6.4    Rest of Middle East and Africa

Chapter 10   Company Profiles

10.1    Augusta Medical Systems

10.2    Boston Scientific Corporation

10.3    Coloplast Corporation

10.4    Medispec Ltd.

10.5    MTS Medical UG

10.6    NOVAmedtek

10.7    Owen Mumford Ltd.

10.8    Promedon

10.9    SILIMED

10.10    STORZ MEDICAL AG

10.11    Zephyr Surgical Implants

10.12    Zimmer Aesthetics

   

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 245
  • Countries covered: 22
  • Pages: 130
 Download Free Sample